National Institutes of Health (NIH)

NIH-sponsored trial of Lassa vaccine opens

Lassa fever is a viral hemorrhagic disease that can be fatal and that causes permanent hearing loss.

NIH-funded study supports use of adenotonsillectomy in this at-risk patient group.

Preclinical study in rodents suggests that uric acid is ready for human clinical testing.

NIH-funded study uses cutting-edge imaging techniques to reconstruct features underlying learning and memory in the mouse brain.

Treatment shows potential to slow the progression of human degenerative eye diseases, including retinitis pigmentosa.

NIH study finds number of steps taken daily may be more important for cancer risk than the intensity of activity.

NIH-funded study reveals variables, such as poverty and education, that may underpin higher rates of heart disease and its risk factors.

NIH trial shows new form of TIL therapy effective against colon, rectum, pancreas, and bile duct tumors.

President Trump nominated Dr. Bhattacharya for the position on Nov. 26, 2024, and he was confirmed by the U.S. Senate on March 25, 2025.

NIH-supported study reveals new risk group for future high blood pressure, heart disease.